CGAS and breast carcinoma: While the activation of cGAS/STING may seem detrimental to tumour proliferation at first, cells carrying pathogenic variants (PVs) of BRCA1/2 genes simultaneously possess many mechanisms to suppress cGAS signaling and evade immune clearance, and hence they also possess greater immune evasion compared to sporadic breast cancers.